kda
ribosom
kinas
rsk
group
serinethreonin
kinas
consist
rsk
isoform
also
design
play
import
role
rasmitogenactiv
protein
kinas
mapk
signal
cascad
direct
downstream
effector
rasextracellular
signalregul
kinas
signal
activ
directli
phosphoryl
activ
turn
activ
variou
signal
event
select
differ
phosphoryl
substrat
upregul
report
numer
human
diseas
play
import
role
regul
divers
cellular
process
thu
aberr
activ
play
critic
role
pathogenesi
organ
dysfunct
damag
review
focu
current
understand
function
role
develop
progress
kidney
diseas
role
well
rsk
cardiovascular
disord
cancer
also
discuss
rasmitogenactiv
protein
kinas
mapk
pathway
import
regul
divers
cellular
process
rasmapk
pathway
initi
ligand
bind
receptor
tyrosin
kinas
rtk
receptor
follow
adaptor
protein
growth
factor
receptorbound
protein
son
sevenless
so
dock
onto
rtk
lead
activ
associ
ra
gtpase
recruit
raf
raf
activ
downstream
extracellular
signalregul
kinas
kda
ribosom
kinas
rsk
group
serinethreonin
kinas
play
import
role
mapk
signal
cascad
direct
downstream
effector
activ
directli
phosphoryl
activ
rsk
turn
activ
variou
signal
event
select
differ
phosphoryl
substrat
modul
divers
cellular
process
cell
prolifer
surviv
motil
forth
thu
aberr
activ
rsk
play
critic
role
pathogenesi
organ
dysfunct
damag
figur
role
kda
ribosom
kinas
one
downstream
mediat
extracellular
signalregul
kinas
erk
pathway
diseas
receptor
tyrosin
kinas
rtk
green
get
activ
ligand
purpl
stimul
activ
dock
protein
growth
factor
receptorbound
protein
son
sevenless
so
so
help
remov
guanosin
diphosph
gdp
rat
sarcoma
ra
allow
bind
guanosin
triphosph
gtp
becom
activ
ra
signal
cascad
begin
ra
activ
raf
kinas
phosphoryl
mitogenactiv
protein
kinas
kinas
extracellular
signalregul
kinas
phosphoryl
variou
downstream
substrat
blue
mediat
divers
cellular
process
purpl
contribut
numer
human
diseas
includ
kidney
diseas
cardiovascular
diseas
cancer
red
first
identifi
xenopu
studi
origin
term
ribosom
kinas
found
respons
phosphoryl
ribosom
protein
later
protein
purifi
renam
base
approxim
kda
weight
kda
rsk
famili
serinethreonin
kinas
protein
famili
consist
isoform
human
term
also
design
kinas
isoform
highli
homolog
around
structur
ident
addit
express
pattern
similar
among
rsk
compar
level
detect
adult
tissu
includ
heart
brain
lung
kidney
pancrea
divers
express
pattern
past
studi
show
express
occur
develop
delet
common
xlink
mental
retard
structur
rsk
noteworthi
member
contain
two
function
divers
domain
call
n
termin
kinas
domain
ntkd
c
termin
kinas
domain
ctkd
ntkd
part
kinas
g
c
agc
famili
ctkd
part
calcium
calmodulin
depend
kinas
camk
famili
function
ctkd
receiv
signal
figur
role
kda
ribosom
kinas
one
downstream
mediat
extracellular
signalregul
kinas
erk
pathway
diseas
receptor
tyrosin
kinas
rtk
green
get
activ
ligand
purpl
stimul
activ
dock
protein
growth
factor
receptorbound
protein
son
sevenless
so
so
help
remov
guanosin
diphosph
gdp
rat
sarcoma
ra
allow
bind
guanosin
triphosph
gtp
becom
activ
ra
signal
cascad
begin
ra
activ
raf
kinas
phosphoryl
mitogenactiv
protein
kinas
kinas
extracellular
signalregul
kinas
phosphoryl
variou
downstream
substrat
blue
mediat
divers
cellular
process
purpl
contribut
numer
human
diseas
includ
kidney
diseas
cardiovascular
diseas
cancer
red
first
identifi
xenopu
studi
origin
term
ribosom
kinas
found
respons
phosphoryl
ribosom
protein
later
protein
purifi
renam
base
approxim
kda
weight
kda
rsk
famili
serinethreonin
kinas
protein
famili
consist
isoform
human
term
also
design
kinas
isoform
highli
homolog
around
structur
ident
addit
express
pattern
similar
among
rsk
compar
level
detect
adult
tissu
includ
heart
brain
lung
kidney
pancrea
divers
express
pattern
past
studi
show
express
occur
develop
delet
common
xlink
mental
retard
structur
rsk
noteworthi
member
contain
two
function
divers
domain
call
n
termin
kinas
domain
ntkd
c
termin
kinas
domain
ctkd
ntkd
part
kinas
g
c
agc
famili
ctkd
part
calcium
calmodulin
depend
kinas
camk
famili
function
ctkd
receiv
signal
erk
autophosphoryl
rsk
import
activ
ntkd
ntkd
activ
ctkd
goe
phosphoryl
downstream
target
domain
connect
linker
region
approxim
amino
acid
larg
contain
regulatori
element
importantli
rsk
isoform
contain
dock
domain
allow
rsk
activ
addit
nearbi
locat
import
rsk
autophosphoryl
may
play
role
dissoci
rsk
activ
progress
rsk
activ
complex
due
multipl
player
activ
site
human
isoform
rsk
four
conserv
phosphoryl
site
ser
ser
ser
thr
mechan
activ
rsk
depend
phosphoryl
site
ser
locat
ntkd
phosphoryl
respons
phosphoinositidedepend
constitut
activ
serin
threonin
kinas
ser
ser
locat
linker
region
kinas
domain
ser
activ
erk
phosphoryl
ser
phosphoryl
ctkd
interestingli
shown
ser
phosphoryl
serv
dock
point
turn
caus
activ
ser
thr
within
ctkd
also
phosphoryl
addit
mechan
activ
mapk
fibroblast
growth
factor
shown
influenc
rsk
regul
mapk
shown
activ
rsk
dendrit
cell
via
mapkactiv
kinas
activ
ctkd
shown
interact
tyrosin
phosphoryl
phosphoryl
promot
erk
bind
caus
activ
rsk
regul
divers
cellular
process
phosphoryl
select
downstream
substrat
constantli
grow
list
ie
shown
promot
cell
prolifer
growth
one
way
impact
cell
prolifer
phosphoryl
max
dimer
allevi
suppress
myc
result
increas
prolifer
also
regul
cell
growth
protein
synthesi
modul
mtor
pathway
specif
influenc
mtor
phosphoryl
tuber
sclerosi
complex
raptor
moreov
phosphoryl
inhibit
glycogen
synthas
kinas
gsk
caus
releas
cyclin
cell
prolifer
induc
translat
initi
factor
protein
synthesi
rsk
also
shown
interact
cfo
transcript
factor
import
phase
cell
cycl
phosphoryl
induc
phase
progress
cell
surviv
also
influenc
known
phosphoryl
bad
decreas
apoptosi
phosphoryl
tumour
suppressor
deathassoci
protein
kinas
dapk
caus
inactiv
shown
influenc
inflamm
transcript
phosphoryl
nuclear
factor
kappalightchainenhanc
activ
b
cell
inhibitor
nuclear
factor
kappa
light
polypeptid
gene
enhanc
bcell
inhibitor
phosphoryl
mapk
induc
macrophag
surviv
also
phosphoryl
downstream
substrat
filamin
phosphoryl
domaincontain
protein
induc
cell
motil
migrat
increas
activ
phosphoryl
implic
aetiolog
variou
diseas
differ
type
cancer
cardiovascular
diseas
kidney
diseas
vitro
erk
shown
regul
multipl
cellular
process
includ
growth
cell
prolifer
surviv
motil
variou
downstream
substrat
differ
cell
type
vivo
cell
higher
express
activ
manifest
abnorm
growth
prolifer
resist
apoptosi
function
incapac
caus
dysfunct
organ
progress
diseas
four
rsk
predominantli
express
kidney
suggest
may
play
uniqu
role
pathogenesi
kidney
diseas
obstructioninduc
fibrot
kidney
phosphoryl
upstream
signal
markedli
induc
obstruct
injuri
activ
correl
sever
kidney
fibrosi
vitro
profibrot
factor
tissuetyp
plasminogen
activ
tpa
induc
phosphoryl
activ
kidney
cell
implic
may
involv
initi
progress
chronic
kidney
diseas
renal
fibrosi
interstiti
fibroblast
myofibroblast
gener
consid
primari
matrixproduc
cell
kidney
number
interstiti
fibroblast
myofibroblast
close
correl
sever
tubulointerstiti
fibrosi
concomit
declin
kidney
function
recent
work
shown
kidney
fibroblast
tpa
bind
receptor
induc
tyrosin
phosphoryl
turn
activ
downstream
pathway
activ
phosphoryl
phosphoryl
downstream
substrat
bad
induc
fibroblast
prolifer
surviv
constitut
activ
inhibit
downstream
mediat
ubiquitin
proteasom
degrad
phosphoryl
inactiv
result
cyclin
stabil
accumul
facilit
fibroblast
entri
phase
induc
cell
prolifer
bad
prodeath
member
protein
famili
phosphoryl
bad
inactiv
prevent
enter
mitochondria
injuri
lead
suppress
cytochrom
c
releas
cytosol
decreas
cytosol
cytochrom
c
reduc
cleavag
activ
caspas
result
cell
surviv
thu
tpa
profibrot
signal
pathway
activ
induc
fibroblast
accumul
contribut
renal
fibrosi
dual
mechan
promot
fibroblast
surviv
c
pathway
induc
fibroblast
prolifer
signal
macrophag
accumul
one
histolog
hallmark
chronic
kidney
diseas
diseas
condit
macrophag
differenti
two
categori
classic
activ
altern
activ
exposur
lipopolysaccharid
lp
macrophag
produc
nitric
oxid
reactiv
oxygen
intermedi
protect
bacteria
viral
pathogen
also
produc
abund
proinflammatori
cytokin
initi
immun
respons
recruit
inflammatori
cell
exagger
damag
exposur
macrophag
produc
polyamin
prolin
help
wound
heal
tissu
repair
discov
phosphoryl
tpa
protect
macrophag
apoptosi
induc
hydrogen
peroxid
staurosporin
activ
novel
downstream
mapk
pathway
intriguingli
tpa
treatment
rest
macrophag
classic
activ
macrophag
altern
activ
macrophag
resist
apoptosi
obstructioninduc
fibrot
kidney
increas
activ
associ
sever
diseas
condit
increas
extracellular
matrix
ecm
accumul
enhanc
macrophag
infiltr
profound
proinflammatori
cytokin
express
thu
promot
surviv
accumul
macrophag
especi
macrophag
produc
panopli
proinflammatori
cytokin
chemokin
result
increas
inflammatori
cell
recruit
sever
inflammatori
respons
excess
kidney
injuri
proteinuria
one
common
manifest
glomerular
diseas
physiolog
condit
plasma
filtrat
glomerular
basement
membran
gbm
result
urin
contain
larg
wast
toxin
protein
larger
albumin
podocyt
cover
outer
surfac
gbm
longinterdigit
foot
process
podocyt
form
filtrat
slit
critic
integr
glomerular
filtrat
barrier
podocyt
termin
differenti
cell
regener
injur
respons
injuri
puromycin
aminonucleosid
pan
podocyt
undergo
apoptosi
detach
gbm
lead
disrupt
integr
glomerular
filtrat
barrier
proteinuria
oh
colleagu
found
calcimimet
induc
signal
cascad
allevi
paninduc
proteinuria
attenu
glomerulosclerosi
improv
glomerular
filtrat
rate
gfr
clarifi
mediat
protect
effect
activ
prosurviv
signal
bad
bclxl
reduc
paninduc
podocyt
apoptosi
damag
diabet
nephropathi
one
lead
caus
end
stage
renal
diseas
histolog
character
thicken
tubular
basal
glomerular
membran
excess
ecm
deposit
progress
mesangi
hypertrophi
mesangi
cell
constitut
total
glomerular
cell
popul
also
contribut
ecm
product
mesangi
cell
hypertrophi
often
follow
matrix
deposit
associ
result
glomerulosclerosi
mediat
hypertroph
effect
hyperglycaemia
da
colleagu
found
induc
activ
mesangi
cell
activ
induc
phosphoryl
inactiv
eukaryot
elong
kinas
lead
decreas
phosphoryl
augment
activ
activ
eventu
induc
protein
synthesi
caus
mesangi
hypertrophi
block
signal
use
dominantneg
inhibit
mesangi
hypertrophi
emerg
evid
also
indic
involv
kidney
diseas
zacchia
colleagu
found
media
acidif
activ
citrat
transport
signal
opossum
kidney
proxim
tubul
cell
suggest
may
play
role
hypocitraturia
kidney
stone
format
mizutani
colleagu
found
sever
acut
respiratori
syndrom
sar
coronaviru
cov
infect
induc
mapkmedi
phosphoryl
phosphoryl
kidney
epitheli
cell
may
one
underli
mechan
virusinduc
kidney
damag
recoveri
acut
kidney
injuri
surviv
epitheli
cell
dedifferenti
migrat
injuri
site
prolifer
redifferenti
establish
epitheli
polar
restor
kidney
function
tanimura
colleagu
found
impli
motil
respons
kidney
epitheli
cell
induc
agent
hepatocyt
growth
factor
hgf
phorbol
pma
epiderm
growth
factor
egf
indic
may
mediat
kidney
regener
repair
acut
injuri
endotheli
cell
ec
singl
layer
mesenchym
cell
line
inner
surfac
blood
vessel
lymphat
mesotheliallin
caviti
ec
separ
tissu
circul
blood
also
play
import
role
mani
physiolog
function
control
vascular
tone
blood
cell
traffick
immun
haemostasi
ec
sens
respond
shear
stress
blood
flow
produc
vasoact
factor
vasodil
vasoconstrictor
procoagul
anticoagul
inflammatori
antiinflammatori
factor
fibrinolyt
antifibrinolyt
factor
oxid
antioxid
factor
factor
help
maintain
normal
function
blood
vasculatur
expos
variou
atherosclerosi
risk
factor
ec
express
increas
cell
adhes
molecul
intercellular
adhes
vascular
cell
adhes
eselectin
enhanc
leukocyt
recruit
initi
inflamm
final
promot
progress
atherosclerosi
disturbedflow
dflow
known
risk
factor
atherosclerosi
activ
ec
activ
phosphoryl
sentrinsmal
ubiquitinlik
modifi
sumo
specif
proteas
induc
nuclear
export
reduc
activ
sumoyl
posttransl
modif
sumo
small
ubiquitinlik
modifi
protein
conjug
target
protein
regul
local
degrad
bind
activ
target
protein
senp
famili
convert
precursor
sumo
matur
sumo
revers
protein
sumoyl
desumoyl
target
protein
activationmedi
nuclear
export
increas
nuclear
sumoyl
lead
ec
apoptosi
inflamm
atherosclerot
plaqu
format
ec
activ
either
associ
erk
directli
phosphoryl
associ
phosphoryl
inhibit
transcript
activ
caus
inhibit
promot
activ
decreas
eno
express
increas
express
lead
atherosclerosi
vu
colleagu
found
ioniz
radiat
induc
activ
ec
activ
increas
activ
express
ec
apoptosi
phosphoryl
regul
transcript
activ
vivo
studi
confirm
mice
expos
radiat
exhibit
higher
endotheli
disturb
flow
area
find
may
help
elucid
underli
mechan
high
incid
cardiovascular
diseas
patient
radiat
treatment
monocyt
macrophag
critic
player
cardiovascular
diseas
involv
process
atherosclerot
lesion
format
progress
cardiac
regener
myocardi
infarct
singh
colleagu
found
activ
variou
combin
antiretrovir
therapi
cart
monocyt
macrophag
activ
phosphoryl
inhibit
activ
reduc
telomer
length
decreas
antioxid
express
result
increas
sensit
monocytesmacrophag
oxid
stress
activ
macrophag
also
induc
express
proinflammatori
gene
decreas
express
efferocytosisrel
gene
result
also
valid
vivo
use
two
differ
transgen
mous
model
atherosclerosi
singh
colleagu
found
overexpress
myeloid
cell
mice
larger
atherosclerot
lesion
necrot
core
plaqu
nontransgen
litterm
control
nlc
mice
dominantneg
myeloid
cell
mice
exhibit
smaller
plaqu
less
develop
necrot
core
ncl
mice
furthermor
monocyt
peripher
whole
blood
carttreat
hivposit
patient
display
increas
activ
sensit
reactiv
oxygen
speci
ro
compar
monocyt
hivneg
individu
thu
key
player
regul
format
progress
atherosclerot
lesion
modul
efferocytosi
inflamm
antioxid
express
senesc
monocyt
macrophag
play
import
role
maintain
cardiac
function
aberr
activ
contribut
progress
myocardi
hypertrophi
heart
failur
itoh
colleagu
found
mediat
ro
protein
kinas
cardiac
troponin
phosphoryl
shown
activ
pressureoverloadinduc
hypertroph
myocardium
guinea
pig
explant
heart
patient
dilat
cardiomyopathi
yamaguchi
colleagu
show
activ
reduc
activ
contribut
develop
cardiac
hypertrophi
mice
express
dysfunct
ryanodin
receptor
ion
channel
colleagu
discov
activ
neonat
ventricular
myocyt
induc
express
cfo
bnp
lead
myocyt
growth
probabl
cardiac
hypertrophi
activ
also
shown
mediat
posit
inotrop
respons
rat
heart
stretch
induc
phosphoryl
activ
serial
protein
kinas
includ
human
myocardium
neonat
rat
cardiac
myocyt
also
appear
play
role
cardiomyopathi
ischemiareperfus
injuri
sinc
report
global
ischemiareperfus
induc
rapid
transient
activ
guinea
pig
heart
jiang
colleagu
found
activ
mediat
cardioprotect
effect
proteas
activ
receptor
rat
heart
ischemiareperfus
model
itoh
colleagu
studi
role
ischem
diabet
myocardium
use
transgen
mice
cardiacspecif
overexpress
wildtyp
ribosom
kinas
found
recoveri
cardiac
function
ischemiareperfus
isol
heart
mice
significantli
impair
comparison
wildtyp
control
le
colleagu
show
activ
diabet
heart
induc
phosphoryl
inhibit
associ
chip
ubiquitin
ligas
bind
decreas
chip
ubiquitin
ligas
activ
suppress
induc
camp
earli
repressor
icer
ubiquitin
degrad
final
promot
cardiac
apoptosi
find
provid
insight
underli
mechan
high
mortal
morbid
myocardi
infarct
diabet
patient
found
activ
inhibit
outward
k
channel
activ
decreas
current
fast
transient
outward
k
current
f
slow
delay
outward
k
current
k
slow
steadyst
k
current
ss
ventricular
myocyt
prolong
qtinterv
thu
play
import
role
cardiac
arrhythmia
downstream
effector
rasrafmekerk
signal
pathway
regul
numer
cell
process
includ
cell
growth
prolifer
surviv
motil
phosphoryl
differ
substrat
regul
variou
downstream
signal
cascad
rsk
wide
studi
cancer
research
includ
tumorigenes
metastasi
chemoresist
gener
thought
promot
mani
tumour
progress
promot
prolifer
surviv
cancer
cell
may
antitumour
function
promot
cell
growth
phosphoryl
substrat
raptor
kinas
lead
activ
mtor
pathway
increas
translat
growth
factor
induc
cell
prolifer
phosphoryl
substrat
cfo
regul
activ
cyclindepend
kinas
increas
protein
level
cyclin
promot
cell
surviv
phosphoryl
substrat
creb
bad
bimel
dapk
decreas
activ
proapoptot
molecul
induc
transcript
prosurviv
gene
also
promot
invas
metastasi
cancer
cell
differ
tumour
breast
colon
kidney
stomach
prostat
mechan
includ
induc
cjundepend
transcript
program
relat
epithelialmesenchym
transit
emt
phosphoryl
block
antimotil
effect
phosphoryl
filamin
suppress
integrin
activ
increas
bind
activ
contrast
lara
colleagu
found
antimetastat
effect
lung
cancer
cell
thu
role
rsk
cancer
contextdepend
far
complic
initi
thought
addit
play
import
role
chemoresist
make
tumour
difficult
cure
raydavid
colleagu
found
rsk
appear
contribut
chemoresist
phosphoryl
checkpoint
kinas
rsk
inhibit
sensit
melanoma
cell
dnadamag
agent
increas
activ
krasmut
nonsmal
cell
lung
cancer
nsclc
known
resist
gener
chemotherapi
ganetespib
inhibitor
promis
therapi
nsclc
howev
efficaci
limit
acquir
resist
chatterje
colleagu
show
activ
pathway
mediat
acquir
resist
ganetespib
bypass
ganetespibinduc
cell
cycl
arrest
aberr
activ
shown
numer
human
diseas
activ
phosphoryl
variou
substrat
contribut
initi
develop
numer
diseas
variou
signal
pathway
common
upstream
mediat
variou
substrat
inhibit
provid
promis
therapeut
strategi
numer
diseas
howev
current
option
specif
inhibit
remain
limit
although
presum
inhibitor
target
upstream
also
inhibit
activ
inhibitor
often
caus
unwant
side
effect
inhibitor
first
identifi
inhibitor
isol
tropic
plant
forsteronia
refracta
howev
applic
limit
poor
vivo
efficaci
ludwik
colleagu
studi
effect
analogu
tripleneg
breast
cancer
tnbc
sinc
around
tnbc
tumour
sampl
show
activ
rsk
found
new
analogu
specif
inhibit
vitro
suppress
prolifer
surviv
migrat
tnbc
cell
vivo
administr
metastat
model
suppress
tnbc
metastat
colon
effici
compar
fdaapprov
mek
inhibitor
trametinib
fmkmea
rskselect
irrevers
inhibitor
use
cardiovascular
studi
ec
activ
combin
high
glucos
low
inhibit
express
eno
induc
express
wherea
incub
ec
fmkmea
block
action
le
colleagu
also
check
therapeut
effect
fmkmea
two
diabet
anim
model
stzinduc
diabet
mice
akita
akita
mice
express
phosphoryl
increas
aorta
diabet
mous
mice
display
increas
leukocyt
roll
decreas
achinduc
vasodil
ec
isol
diabet
mice
show
increas
express
eselectin
decreas
express
eno
howev
fmkmea
treatment
dysfunct
ec
vasculatur
amelior
addit
fmkmea
treatment
shown
inhibit
atherosclerot
plaqu
format
apoeatherosclerosi
anim
model
find
implic
inhibit
promis
therapeut
strategi
diabetesmedi
atherosclerosi
anoth
confirm
inhibitor
rsk
least
shi
colleagu
found
improv
left
ventricular
pressur
decreas
ischemiareperfus
suggest
rsk
inhibit
may
promis
treatment
myocardi
infarct
shown
inhibit
activ
block
effect
vivo
vitro
system
takada
colleagu
found
administr
protect
mice
experiment
autoimmun
encephalomyel
reduc
infiltr
cell
cn
decreas
mrna
level
cell
thu
rsk
appear
promis
therapeut
target
multipl
sclerosi
notabl
inhibit
studi
carri
anim
futur
studi
regard
aspect
well
develop
effici
specif
inhibitor
warrant
clear
rsk
mediat
variou
signal
pathway
modul
divers
cellular
process
play
critic
role
pathogenesi
progress
human
diseas
note
effect
often
context
depend
relat
differ
initi
receptor
downstream
substrat
cell
type
challeng
regard
diseas
pathophysiolog
well
develop
specif
therapi
target
remain
answer
futur
studi
author
contribut
kh
propos
wrote
manuscript
saw
wrote
manuscript
fund
research
fund
nation
institut
health
nih
grant
number
american
heart
associ
grant
number
author
declar
conflict
interest
